|
1N26
Crystal Structure of the extra-cellular domains of Human Interleukin-6 Receptor alpha chain
Deposited 2002-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
20–344(325 aa)
Fragment:IL-6R extral-cellular domains
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
SO4 SULFATE ION × 4
CYS CYSTEINE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;300 K;ammonium sulphate, PEG 3350, sodium citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 300K
|
Resolution 2.40 Å
R-free 0.290
|
|
1P9M
Crystal structure of the hexameric human IL-6/IL-6 alpha receptor/gp130 complex
Deposited 2003-05-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
115–315(201 aa)
Fragment:extracellular domains D2 - D3
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;Sodium formate, Sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 3.65 Å
R-free 0.334
|
|
2ARW
The solution structure of the membrane proximal cytokine receptor domain of the human interleukin-6 receptor
Deposited 2005-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
212–336(125 aa)
Fragment:Third extracellular domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;293 K;Ionic strength (raw mmCIF value) 50mM phosphate;Pressure ambient
NMR sample composition
20mM phosphatebuffer pH 5.0, 95% H2O, 5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
5FUC
Biophysical and cellular characterisation of a junctional epitope antibody that locks IL-6 and gp80 together in a stable complex: implications for new therapeutic strategies
Deposited 2016-01-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
111–322(212 aa)
Fragment:RESIDUES 20-33 AND RESIDUES 111-322
|
Mutation:YES
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M MES, PH 6.5, 14% PEG20K
|
Resolution 2.70 Å
R-free 0.287
|
|
5FUC
Biophysical and cellular characterisation of a junctional epitope antibody that locks IL-6 and gp80 together in a stable complex: implications for new therapeutic strategies
Deposited 2016-01-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
111–322(212 aa)
Fragment:RESIDUES 20-33 AND RESIDUES 111-322
|
Mutation:YES
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M MES, PH 6.5, 14% PEG20K
|
Resolution 2.70 Å
R-free 0.287
|
|
8D82
Cryo-EM structure of human IL-6 signaling complex in detergent: model containing full extracellular domains
Deposited 2022-06-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
20–331(312 aa)
Chain G
20–331(312 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.22 Å
|
|
8IOW
Cryo-EM structure of the sarilumab Fab/IL-6R complex
Deposited 2023-03-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D2
1–365(365 aa)
Chain I
1–365(365 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
8J6F
Cryo-EM structure of the Tocilizumab Fab/IL-6R complex
Deposited 2023-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
122–131(10 aa)
Chain I
1–365(365 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
|
8QY5
Structure of interleukin 6.
Deposited 2023-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–468(468 aa)
Chain F
1–468(468 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8QY6
Structure of interleukin 6 (gp130 P496L mutant).
Deposited 2023-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
1–468(468 aa)
Chain F
1–468(468 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.16 Å
|